Literature DB >> 6824987

Modification by halogenated anaesthetics of chronotropic response during reversal of neuromuscular blockade.

S K Samra, U A Pandit, S K Pandit, S P Kothary.   

Abstract

The effect of halothane and enflurane on changes in heart rate during reversal of neuromuscular block was compared in 48 adult patients. Premedication and anaesthetic technique were standardized. Either halothane or enflurane was the primary anaesthetic while pancuronium was used in all patients to achieve muscle relaxation. Ventilation was mechanically controlled and PaCO2 was between 30-40 mmHg. The neuromuscular block was reversed by an intravenous injection of atropine 1.2 mg and neostigmine 2.5 mg, given either separately or simultaneously, in different patient subgroups. Heart rate changes were significantly different between the halothane and enflurane groups. In general, reversal of neuromuscular block was accompanied by less fluctuations in heart rate after enflurane as compared to halothane anaesthesia. Simultaneous injection of atropine and neostigmine modified the tachycardiac response in the halothane sub-group only. Our observations suggest that use of enflurane offers an advantage over halothane in those patients in whom rapid fluctuations in heart rate during reversal of neuromuscular block may be dangerous.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824987     DOI: 10.1007/bf03007716

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  11 in total

1.  The chronotropic and inotropic effects of halothane. A comparison of effects in normal and chronically cardiac denervated dogs.

Authors:  D H MORROW; T E GAFFNEY; J E HOLMAN
Journal:  Anesthesiology       Date:  1961 Nov-Dec       Impact factor: 7.892

2.  Cardiovascular effects of enflurane anesthesia during controlled ventilation in man.

Authors:  R K Calverley; N T Smith; C Prys-Roberts; E I Eger; C W Jones
Journal:  Anesth Analg       Date:  1978 Nov-Dec       Impact factor: 5.108

3.  The effects of atropine and neostigmine on heart rate and rhythm. Recommendation for their use to reverse residual neuromuscular block.

Authors:  V Rosner; E R Kepes; F F Foldes
Journal:  Br J Anaesth       Date:  1971-11       Impact factor: 9.166

4.  Cardiovascular effects of halothane in man.

Authors:  E I Eger; N T Smith; R K Stoelting; D J Cullen; L B Kadis; C E Whitcher
Journal:  Anesthesiology       Date:  1970-05       Impact factor: 7.892

5.  Modification by light cyclopropane and halothane anesthesia of the chronotropic effect of atropine in man.

Authors:  O B Munchow; J S Denson
Journal:  Anesth Analg       Date:  1965 Nov-Dec       Impact factor: 5.108

6.  Effects of administration of atropine and neostigmine in man.

Authors:  A Ovassapian
Journal:  Anesth Analg       Date:  1969 Mar-Apr       Impact factor: 5.108

7.  Mechanisms of chronotropic effects of volatile inhalation anesthetics.

Authors:  G Krisna; R R Paradise
Journal:  Anesth Analg       Date:  1977 Mar-Apr       Impact factor: 5.108

8.  A comparison of glycopyrrolate and atropine during reversal of nondepolarizing neuromuscular block with neostigmine.

Authors:  G W Ostheimer
Journal:  Anesth Analg       Date:  1977 Mar-Apr       Impact factor: 5.108

9.  A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man.

Authors:  R R Johnston; I I Eger EI; C Wilson
Journal:  Anesth Analg       Date:  1976 Sep-Oct       Impact factor: 5.108

10.  Modification of chronotropic response to anticholinergics by halogenated anaesthetics in children.

Authors:  S K Samra; P J Cohen
Journal:  Can Anaesth Soc J       Date:  1980-11
View more
  2 in total

1.  Atropine-neostigmine mixture: a dose-response study.

Authors:  M Naguib; M Gomaa
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

2.  Effect of halogenated anaesthetics on heart rate changes during reversal of neuromuscular block with glycopyrrolate and neostigmine.

Authors:  S K Samra; U Pandit; S K Pandit; S P Kothary
Journal:  Can Anaesth Soc J       Date:  1984-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.